REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma

Blood

Volumn 87, Issue 1, 1996, Pages 25-29

  Houldsworth, Jane ^a   Mathew, Susan ^a   Rao, Pulivarthi H ^a   Dyomina, Katerina ^a   Louie, Diane C ^a   Parsa, Nasser ^a   Offit, Kenneth ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 2P; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA PROBE; DOUBLE MINUTE CHROMOSOME; GENE AMPLIFICATION; GENE MAPPING; HUMAN; HUMAN TISSUE; KARYOTYPING; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR GROWTH;

EID: 0030052683     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.25.25     Document Type: Article

References (34)

1. Weisenburger DD: Pathological classification of non-Hodgkin's lymphoma for epidemiological studies. Cancer Res 52:s5456, 1992 (suppl)
2. Armitage JO: Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023, 1993
3. Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO: Prognostic factors in aggressive malignant lymphomas: Description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 9:211, 1991
4. Dalla-Favera R, Ye BH, Lo Coco F, Gaidano G, Lista F, Knowles DM, Louie DC, Offit K, Chaganti RSK: Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol 5:s55, 1994
5. Schwab M, Amler LC: Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosom Cancer 1:181, 1990
6. Yunius JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M: Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316:79, 1987
7. Ben-Yehuda D, Houldsworth J, Parsa NZ, Chaganti RSK: Gene amplification in non-Hodgkin's lymphoma. Br J Haematol 86:792, 1994
8. Amakawa R, Fukuhara S, Ohno H, Tanabe S, Horii M, Matsuyama F, Kato I, Kakita T, Nagauchi O: Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14; 18 translocation. Cancer Res 50:2423, 1990
9. Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ: Alterations at the rel locus in human lymphoma. Oncogene 6:1235, 1991
10. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818, 1992
11. Kallioneimi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231, 1994
12. Houldsworth J, Chaganti RSK: Comparative genomic hybridization: An overview. Am J Pathol 145:1253, 1994
13. Mathew S, Murty VVVS, Dalla-Favera R, Chaganti RSK: Chromosomal localization of genes encoding the transcription factors, c-rel, NF-κBp50, NF-κBp65, and lyt-10 by fluorescence in situ hybridization. Oncogene 8:191, 1993
14. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosom Cancer 3:189, 1991
15. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508, 1991
16. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
17. Samaniego F, Rodriguez E, Houldsworth J, Murty VVVS, Ladanyi M, Lele KP, Chen Q, Dmitrovsky E, Geller NL, Reuter V, Jhanwar SC, Bosl GJ, Chaganti RSK: Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplification. Genes Chromosom Cancer 1:289, 1990
18. Thanos D, Maniatis T: NF-κB: A lesson in family values. Cell 80:529, 1995
19. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156, 1994
20. Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux B: Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9:2717, 1994
21. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203, 1994
22. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:401, 1995
23. Raghoebier S, Kramer MHH, van Krieken JHJM, de Jong D, Limpens J, Kluin-Nelemans JC, van Ommen GJB, Kluin PhM: Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood 78:2680, 1991
24. Clark HM, Jones DB, Wright DH: Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol 166:129, 1992
25. Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med 331:74, 1994
26. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405, 1994
27. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141, 1994
28. Liou H-C, Sha WC, Scott ML, Baltimore D: Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 14:5349, 1994
29. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075, 1991
30. Ohno H, Takimoto G, McKeithan TW: The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991, 1990
31. Narayanan R, Klement JF, Ruben SM, Higgins KA, Rosen CA: Identification of a naturally occurring transforming variant of the p65 subunit of NF-κB. Science 256:367, 1992
32. Gilmore TD: Malignant transformation by mutant Rel proteins. Trends Genet 7:318, 1991
33. Kralova J, Schatzle JD, Bargmann W, Bose HR Jr: Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids. J Virol 68:2073, 1994
34. Abbadie C, Kabrun N, Bouali F, Smardova J, Stehelin D, Vandenbunder B, Enrietto PJ: High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75:899, 1993